1887

oa Cardiovascular Journal of Africa - Antibiotic therapy in bacterial endocarditis

 

Abstract

Despite advances in antimicrobial therapy, endocarditis continues to be a difficult therapeutic problem. In countries where streptococci remain the commonest cause of this disease, penicillin and gentamicin are still the best empirical choices. Studies have allowed some refining of therapy by identifying criteria, on the basis of which decisions can be made about the duration of therapy and the need for synergistic aminoglycosides. In prosthetic endocarditis the preponderance of staphylococci as causative agents dictates the empirical use of vancomycin until sensitivity data are available.

Loading

Article metrics loading...

/content/cardio1/7/4/AJA10159657_485
1996-08-01
2016-12-08
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error